Theriva Total Assets from 2010 to 2024

TOVX Stock

USD 1.28 0.02 1.59%

Theriva Biologics Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

1993-03-31

Previous Quarter

42.4 M

Current Value

40.1 M

Quarterly Volatility

22.1 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Theriva Biologics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Theriva Biologics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 101.5 K, Total Revenue of 0.0 or Other Operating Expenses of 13.9 M, as well as many indicators such as Price To Sales Ratio of 241, Dividend Yield of 0.0 or PTB Ratio of 0.17. Theriva financial statements analysis is a perfect complement when working with Theriva Biologics Valuation or Volatility modules.

Check out the analysis of Theriva Biologics Correlation against competitors.

For more information on how to buy Theriva Stock please use our How to Invest in Theriva Biologics guide.

Latest Theriva Biologics' Total Assets Growth Pattern

Below is the plot of the Total Assets of Theriva Biologics over the last few years. Total assets refers to the total amount of Theriva Biologics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Theriva Biologics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Theriva Biologics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Theriva Biologics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 55.22 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Theriva Total Assets Regression Statistics

	Arithmetic Mean	29,432,797
	Geometric Mean	20,624,683
	Coefficient Of Variation	78.59
	Mean Deviation	18,641,889
	Median	19,144,000
	Standard Deviation	23,130,830
	Sample Variance	535T
	Range	70.1M
	R-Value	0.78
	Mean Square Error	221.3T
	R-Squared	0.62
	Significance	0.0005
	Slope	4,059,145
	Total Sum of Squares	7490.5T

Theriva Total Assets History

	2024	58 M
	2023	55.2 M
	2022	71.9 M
	2021	70.4 M
	2020	8.4 M
	2019	17.2 M
	2018	30.1 M

Other Fundumenentals of Theriva Biologics

Intangibles To Total Assets

Theriva Biologics Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Short Term Debt	Net Receivables	Short Term Investments	Intangible Assets	Common Stock	Good Will	Net Tangible Assets	Net Invested Capital	Capital Stock	Net Working Capital	Property Plant Equipment	Long Term Debt	Deferred Long Term Liab	Short Long Term Debt
Total Assets		0.94	-0.83	-0.76	0.01	0.46	0.81	0.48	0.46	-0.35	0.36	-0.27	0.71	0.91	0.89	-0.92	0.65	0.88	-0.48	-0.46	0.47
Total Stockholder Equity	0.94		-0.84	-0.68	-0.18	0.13	0.81	0.38	0.39	-0.29	0.29	-0.3	0.61	0.87	0.88	-0.9	0.68	0.85	-0.39	-0.37	0.38
Net Debt	-0.83	-0.84		0.56	-0.01	-0.23	-0.98	0.0	0.01	0.32	-0.32	0.06	-0.21	-0.71	-0.84	0.68	-0.84	-0.65	0.01	0.0	0.0
Retained Earnings	-0.76	-0.68	0.56		-0.16	-0.51	-0.55	-0.53	-0.49	0.52	-0.52	0.49	-0.62	-0.56	-0.47	0.74	-0.14	-0.67	0.5	0.46	-0.49
Accounts Payable	0.01	-0.18	-0.01	-0.16		0.55	0.1	-0.1	-0.15	-0.23	0.24	-0.02	-0.14	-0.23	-0.24	0.23	-0.19	-0.18	0.1	0.08	-0.09
Total Liab	0.46	0.13	-0.23	-0.51	0.55		0.25	0.4	0.3	-0.32	0.33	-0.05	0.47	0.32	0.26	-0.3	0.08	0.32	-0.35	-0.33	0.34
Total Current Assets	0.81	0.81	-0.98	-0.55	0.1	0.25		0.03	-0.05	-0.35	0.33	-0.07	0.19	0.66	0.82	-0.64	0.79	0.66	0.05	0.08	-0.07
Short Term Debt	0.48	0.38	0.0	-0.53	-0.1	0.4	0.03		0.84	-0.29	0.21	-0.41	0.85	0.52	0.32	-0.57	-0.17	0.68	-0.82	-0.67	0.75
Net Receivables	0.46	0.39	0.01	-0.49	-0.15	0.3	-0.05	0.84		-0.2	0.22	-0.34	0.8	0.6	0.3	-0.63	-0.05	0.55	-0.98	-0.93	0.96
Short Term Investments	-0.35	-0.29	0.32	0.52	-0.23	-0.32	-0.35	-0.29	-0.2		-0.98	0.8	-0.17	-0.16	-0.13	0.21	0.01	-0.24	0.16	0.11	-0.14
Intangible Assets	0.36	0.29	-0.32	-0.52	0.24	0.33	0.33	0.21	0.22	-0.98		-0.81	0.18	0.16	0.12	-0.22	0.02	0.18	-0.18	-0.18	0.19
Common Stock	-0.27	-0.3	0.06	0.49	-0.02	-0.05	-0.07	-0.41	-0.34	0.8	-0.81		-0.38	-0.07	0.02	0.21	0.27	-0.21	0.31	0.29	-0.3
Good Will	0.71	0.61	-0.21	-0.62	-0.14	0.47	0.19	0.85	0.8	-0.17	0.18	-0.38		0.71	0.54	-0.77	0.11	0.76	-0.8	-0.76	0.79
Net Tangible Assets	0.91	0.87	-0.71	-0.56	-0.23	0.32	0.66	0.52	0.6	-0.16	0.16	-0.07	0.71		0.93	-0.94	0.73	0.88	-0.61	-0.58	0.6
Net Invested Capital	0.89	0.88	-0.84	-0.47	-0.24	0.26	0.82	0.32	0.3	-0.13	0.12	0.02	0.54	0.93		-0.87	0.85	0.87	-0.29	-0.26	0.28
Capital Stock	-0.92	-0.9	0.68	0.74	0.23	-0.3	-0.64	-0.57	-0.63	0.21	-0.22	0.21	-0.77	-0.94	-0.87		-0.56	-0.92	0.61	0.58	-0.6
Net Working Capital	0.65	0.68	-0.84	-0.14	-0.19	0.08	0.79	-0.17	-0.05	0.01	0.02	0.27	0.11	0.73	0.85	-0.56		0.5	0.03	-0.01	-0.01
Property Plant Equipment	0.88	0.85	-0.65	-0.67	-0.18	0.32	0.66	0.68	0.55	-0.24	0.18	-0.21	0.76	0.88	0.87	-0.92	0.5		-0.54	-0.43	0.49
Long Term Debt	-0.48	-0.39	0.01	0.5	0.1	-0.35	0.05	-0.82	-0.98	0.16	-0.18	0.31	-0.8	-0.61	-0.29	0.61	0.03	-0.54		0.96	-0.99
Deferred Long Term Liab	-0.46	-0.37	0.0	0.46	0.08	-0.33	0.08	-0.67	-0.93	0.11	-0.18	0.29	-0.76	-0.58	-0.26	0.58	-0.01	-0.43	0.96		-0.99
Short Long Term Debt	0.47	0.38	0.0	-0.49	-0.09	0.34	-0.07	0.75	0.96	-0.14	0.19	-0.3	0.79	0.6	0.28	-0.6	-0.01	0.49	-0.99	-0.99

Click cells to compare fundamentals

About Theriva Biologics Financial Statements

Theriva Biologics investors use historical fundamental indicators, such as Theriva Biologics' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Theriva Biologics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	55.2 M	58 M
Intangibles To Total Assets	0.46	0.48

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Theriva Stock Analysis

When running Theriva Biologics' price analysis, check to measure Theriva Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theriva Biologics is operating at the current time. Most of Theriva Biologics' value examination focuses on studying past and present price action to predict the probability of Theriva Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theriva Biologics' price. Additionally, you may evaluate how the addition of Theriva Biologics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC